This new State-of-the-Art review provides an exhaustive overview of contemporary diagnosis, risk stratification, and early management of NSTE-ACS, integrating ECG patterns, hs-troponin algorithms, guideline-directed timing of angiography, and the role of intravascular and

The December issue of EuroIntervention is out now featuring: ➡️State-of-the-art on - NSTE-ACS management - Calcified nodules in PCI ➡️New evidence on β-blockers post-MI ➡️Abbreviated antiplatelet therapy in HBR patients with CKD ➡️Thrombosis after Reducer

30 agents. Cameras ordered off. @erictrump recounts the moment the raid began.

This new Consensus provided a comprehensive framework for managing patients with transvalvular CIED leads undergoing transcatheter #tricuspid interventions. It clarified mechanisms of lead–valve interaction, outlined risks and implications of lead jailing, and defined when lead

🎧 New Turning Point podcast! This week, Lars Søndergaard reflects on a career shaped by unexpected opportunities — from structural interventions & first-in-human procedures to major trials like NOTION and key work on PFO. He also shares pragmatic advice for young cardiologists:

The CANNULATE TAVR EXPANDED study reported high feasibility of coronary cannulation after TAVI with the Evolut FX. Post-TAVI CT showed high rates of commissural and coronary alignment, while misalignment was the strongest predictor of delayed or suboptimal cannulation. #TAVI

My sincere thanks to ABC’s Nightline for having me on last night to discuss the Walshe case. It was an honor to join a program that has spent decades bringing important stories to the public with clarity, depth, and integrity. Here is the link to last night's segment:

This Viewpoint by Won-Keun Kim and Helge Möllmann reviewed the factors surrounding the discontinuation of the ACURATE transcatheter valve platform, contextualising recent trial data and real-world insights to inform ongoing discussions in TAVI practice. #TAVI

Early results from the TRICURE FIH study show that the Topaz TTVR system achieved complete TR elimination, with all patients reaching none/mild TR at 30 days and 100% device success. A step forward for TTVR in high-risk TR patients. @PatrizioLancel2 @LeopoldOliver86

New data from the OCEAN-TAVI registry: among 2,699 pts treated with SAPIEN 3, long-term outcomes and BE-THV durability were comparable between small and large aortic annuli. BVF remained infrequent (3.2% at 7 yrs), and annular size showed no association with mortality or BVF.

Happening at PCR London valves 2025: 🔎Zoom on the most impactful papers on valvular heart disease published this year in EuroIntervention #PCRLV

We get to work with a lot of incredible companies that come out of @ycombinator . Like @marvy_101 says “I don’t think there are many places where you get to work with such world class people”. Here’s to all the companies we get to build with, like @sobhan_nejad @usebland,

📢 Prepare to welcome a new member of the EuroIntervention Journal Family - a new peer-reviewed journal is on its way.! We're delighted to announce that in 2026 we will be launching EuroIntervention Case Reports - the first and only case report journal dedicated to

New data from the OCEAN-TAVI CT substudy: hypoattenuating leaflet thickening (HALT) occurred in 21.3% of patients after SAPIEN 3 Ultra RESILIA TAVI. HALT was strongly linked to THV deformation and asymmetric leaflet expansion, while the revised leaflet suspension design showed no

Another Simultaneous Publication #PCRLV today! Early clinical results of the DurAVR balloon-expandable THV in small aortic annuli show excellent 30-day performance: 🔹 93% technical success 🔹 Mean gradient 8.2 mmHg 🔹 EOAi 2.2 cm² 🔹 Moderate PPM only 3% Promising early

Simultaneously published with #PCRLV : @GilbertTangMD et al. present 5-year outcomes of the early-generation Intrepid transapical TMVR system, demonstrating sustained MR elimination, stable hemodynamics and consistent clinical improvement. https://t.co/ydCBnsR4Jc @psorajja ;

Bicuspid is no longer a niche. In this new SOTA, @didier_tchetche et al walk through TAVI in BAV: phenotypes, CT sizing (BAVARD, circle, CASPER), procedural tricks, long-term concerns and the need for TAVI vs SAVR RCTs. #TAVI #cardiotwitter #CardioX #CardioEd #PCRLV

‼️New issue – PCR London Valves Edition‼️ ✅SOTA on TAVI in bicuspid AS ✅ EHRA/EAPCI expert consensus on tricuspid interventions with RV leads; ✅ Viewpoint on ACURATE’s discontinuation; ✅ new data on coronary cannulation after Evolut FX, ✅HALT with SAPIEN Ultra

Some great practical tips as you get ready for #PCRLV 🇬🇧 Don’t forget your ETA 😉

London Valves is just around the corner, guys!! A ton of sensational education content in the pipeline🔥 Will you be onboard this year? #PCRlondonValves @PCRonline

H2H | What is the future of coronary interventions: DES, DEB and/or BRS?

From trial to real-world care In the Danish registry recently published, @JacobsenRavn et al. showed prasugrel’s advantage over ticagrelor after PCI for MI — confirming ISAR-REACT 5. @adnan_kastrati & @FiorenzoSimo discuss how real-world evidence closes the loop from RCTs to